This month, AMA Journal of Ethics' theme editor Cameron Waldman, a second-year medical student at Albany Medical College, interviewed Aron Janssen, MD, about how healthcare professionals can better serve their transgender patients.
The FDA's decision to put a black-box warning on antidepressant labels may be misleading because it implies that antidepressants have definitely been found to increase suicidality in adolescents, when in fact there is merely a lack of clear evidence about their safety.
The ad hoc capacity granted underage patients to consent to certain medical services cannot be allowed to thwart the reason it is granted in the first place—to protect the health of minors.
Although there is a strong tendency to medicate children and adolescents for all types of behavioral problems, physicians must be prudent in also using nonpharmaceutical treatments.
Current research suggests that the most effective treatment for pediatric depression is a combination of cognitive behavioral therapy and antidepressant medication, but continued funding for independent research is necessary.